Table 2. Characteristics of participants without overt HF (sample 1).
| CHD (N = 185) | Metabolic Syndrome (N = 1595) | Hypertension (N = 482) | Obesity (N = 383) | Referent group (N = 2891) | |
|---|---|---|---|---|---|
| Age at Index Exam, years | 68.3 (9.6) | 56.6 (14.0) | 56.8 (14.1) | 44.4 (11.8) | 43.3 (12.7) |
| Women, N (%) | 65 (35%) | 732 (46%) | 253 (52%) | 215 (56%) | 1745 (60%) |
| BMI, kg/m2 | 28.9 (4.8) | 30.4 (5.1) | 26.2 (4.4) | 33.3 (3.3) | 24.1 (2.9) |
| Obesity | 69 (37%) | 733 (46%) | 76 (16%) | 383 (100%) | 0 (0%) |
| Systolic blood pressure, mm Hg | 129 (16) | 130 (16) | 137 (16) | 116 (9) | 112 (11) |
| Diastolic blood pressure, mm Hg | 70 (9) | 78 (11) | 82 (11) | 75 (7) | 72 (8) |
| Hypertension treatment, N (%) | 138 (75%) | 742 (47%) | 272 (56%) | 0 (0%) | 0 (0%) |
| Hypertension, N (%) | 146 (79%) | 976 (61%) | 482 (100%) | 0 (0%) | 0 (0%) |
| Diabetes, N (%) | 49 (26%) | 244 (15%) | 0 (0%) | (0%) | (0%) |
| Current smoker, N (%) | 16 (9%) | 198 (12%) | 52 (11%) | 39 (10%) | 411 (14%) |
| Coronary heart disease, N (%) | 185 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
| Metabolic syndrome, N (%) | 146 (79%) | 100% | 0 (0%) | 0 (0%) | 0 (0%) |
| Micro albuminuria, N (%) | 28 (15%) | 100 (6%) | 28 (6%) | 11 (3%) | 56 (2%) |
| Estimated GFR (ml/min/1.73 m2) | 74.4 (17.2) | 88.3 (19.0) | 87.9 (18.5) | 100.5 (15.1) | 99.7 (15.9) |
| Chronic kidney disease, N (%) | 52 (28%) | 203 (13%) | 56 (12%) | 13 (4%) | 86 (3%) |
| Atrial fibrillation | 27 (15%) | 32 (2%) | 6 (1%) | 3 (1%) | 19 (1%) |
| COPD* | 16 (12%) | 65 (8%) | 18 (7%) | 5 (6%) | 38 (7%) |
* Percentages are calculated based on the sample where data were available (only in the Offspring sample, at examination cycle 8).